Published in JAMA on January 05, 2000
The causal relation between human papillomavirus and cervical cancer. J Clin Pathol (2002) 14.73
Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol (2011) 5.59
Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J Natl Cancer Inst (2010) 3.95
Human papillomavirus and cervical cancer. Clin Microbiol Rev (2003) 3.90
Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica. Vaccine (2008) 3.17
Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ (2001) 2.56
Human papillomavirus genotype specificity of hybrid capture 2. J Clin Microbiol (2008) 2.51
Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study. J Clin Microbiol (2007) 2.27
Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer (2001) 2.26
Incidence, clearance and predictors of human papillomavirus infection in women. CMAJ (2003) 2.04
Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br J Cancer (2003) 1.90
A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study. Cancer Epidemiol Biomarkers Prev (2011) 1.82
Simultaneous amplification and identification of 25 human papillomavirus types with Templex technology. J Clin Microbiol (2006) 1.75
Comparison of the SPF10-LiPA system to the Hybrid Capture 2 Assay for detection of carcinogenic human papillomavirus genotypes among 5,683 young women in Guanacaste, Costa Rica. J Clin Microbiol (2007) 1.64
Development of a sensitive and specific assay combining multiplex PCR and DNA microarray primer extension to detect high-risk mucosal human papillomavirus types. J Clin Microbiol (2006) 1.61
Comparison of two PCR-based human papillomavirus genotyping methods. J Clin Microbiol (2008) 1.59
A comparison of linear array and hybrid capture 2 for detection of carcinogenic human papillomavirus and cervical precancer in ASCUS-LSIL triage study. Cancer Epidemiol Biomarkers Prev (2008) 1.53
HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br J Cancer (2001) 1.52
Common genetic variants and risk for HPV persistence and progression to cervical cancer. PLoS One (2010) 1.43
Looking ahead: a case for human papillomavirus testing of self-sampled vaginal specimens as a cervical cancer screening strategy. Int J Cancer (2011) 1.41
HPV types and cofactors causing cervical cancer in Peru. Br J Cancer (2001) 1.41
Current status of cervical cancer and HPV infection in Korea. J Gynecol Oncol (2009) 1.40
Systems analysis of real-world obstacles to successful cervical cancer prevention in developing countries. Am J Public Health (2006) 1.39
Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised setting. Br J Cancer (2005) 1.37
Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. J Infect Dis (2009) 1.35
Invited commentary: is monitoring of human papillomavirus infection for viral persistence ready for use in cervical cancer screening? Am J Epidemiol (2008) 1.35
Human papillomavirus testing with the hybrid capture 2 assay and PCR as screening tools. J Clin Microbiol (2004) 1.33
Evaluation of a prototype real-time PCR assay for carcinogenic human papillomavirus (HPV) detection and simultaneous HPV genotype 16 (HPV16) and HPV18 genotyping. J Clin Microbiol (2009) 1.29
Cervical cancer trends in the United States: a 35-year population-based analysis. J Womens Health (Larchmt) (2012) 1.28
An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme. Br J Cancer (2004) 1.21
Results of human papillomavirus DNA testing with the hybrid capture 2 assay are reproducible. J Clin Microbiol (2002) 1.14
Agreement between self- and clinician-collected specimen results for detection and typing of high-risk human papillomavirus in specimens from women in Gugulethu, South Africa. J Clin Microbiol (2007) 1.12
Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers. J Clin Pathol (2006) 1.11
Recent advances: Sexually transmitted infections. BMJ (2001) 1.10
Comparison of MY09/11 consensus PCR and type-specific PCRs in the detection of oncogenic HPV types. J Cell Mol Med (2007) 1.09
Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions. Br J Cancer (2004) 1.08
Facile, comprehensive, high-throughput genotyping of human genital papillomaviruses using spectrally addressable liquid bead microarrays. J Mol Diagn (2005) 1.07
Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer. J Clin Microbiol (2003) 1.05
Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: feasibility study for the HPV persistence and progression cohort. J Virol Methods (2007) 1.05
Detection of high-risk papillomavirus DNA with commercial invader-technology-based analyte-specific reagents following automated extraction of DNA from cervical brushings in ThinPrep media. J Clin Microbiol (2007) 1.04
Human papillomavirus testing for primary cervical cancer screening. JAMA (2000) 1.03
Optimal threshold for a positive hybrid capture 2 test for detection of human papillomavirus: data from the ARTISTIC trial. J Clin Microbiol (2009) 1.03
Accuracy and cost-effectiveness of cervical cancer screening by high-risk human papillomavirus DNA testing of self-collected vaginal samples. J Low Genit Tract Dis (2010) 0.99
Bayesian estimation of performance measures of cervical cancer screening tests in the presence of covariates and absence of a gold standard. Cancer Inform (2008) 0.97
Validation of an automated detection platform for use with the roche linear array human papillomavirus genotyping test. J Clin Microbiol (2008) 0.96
Screening tests: a review with examples. Inhal Toxicol (2014) 0.94
Single nucleotide polymorphisms in the PRDX3 and RPS19 and risk of HPV persistence and cervical precancer/cancer. PLoS One (2012) 0.93
Factors affecting the detection rate of human papillomavirus. Ann Fam Med (2004) 0.93
Estimating the cost of cervical cancer screening in five developing countries. Cost Eff Resour Alloc (2006) 0.93
Correlation of DNA ploidy with progression of cervical cancer. J Cancer Epidemiol (2008) 0.92
Evaluation of the polyclonal ELISA HPV serology assay as a biomarker for human papillomavirus exposure. Sex Transm Dis (2011) 0.91
Dose-escalation of human anti-interferon-α receptor monoclonal antibody MEDI-546 in subjects with systemic sclerosis: a phase 1, multicenter, open label study. Arthritis Res Ther (2014) 0.90
Detection of carcinogenic human papillomavirus in specimens collected with a novel self-sampling device. J Clin Microbiol (2006) 0.89
The laboratory diagnosis of genital human papillomavirus infections. Can J Infect Dis Med Microbiol (2005) 0.89
An intelligent clinical decision support system for patient-specific predictions to improve cervical intraepithelial neoplasia detection. Biomed Res Int (2014) 0.88
Comparison of Hybrid capture 2 testing at different thresholds with cytology as primary cervical screening test. Br J Cancer (2010) 0.88
Common genetic variation in TP53 and risk of human papillomavirus persistence and progression to CIN3/cancer revisited. Cancer Epidemiol Biomarkers Prev (2009) 0.88
Lessons learned from successful Papanicolaou cytology cervical cancer prevention in the Socialist Republic of Vietnam. Diagn Cytopathol (2011) 0.87
Does pretreatment HPV viral load correlate with prognosis in patients with early stage cervical carcinoma? J Gynecol Oncol (2008) 0.86
Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference. J Clin Pathol (2001) 0.86
Ethnic differences in allelic distribution of IFN-g in South African women but no link with cervical cancer. J Carcinog (2003) 0.85
HPV testing for cervical cancer screening appears more cost-effective than Papanicolau cytology in Mexico. Cancer Causes Control (2010) 0.83
Cancer of the Uterine Cervix. BMC Womens Health (2004) 0.83
Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing. Br J Cancer (2000) 0.83
Denaturing high-performance liquid chromatography for detecting and typing genital human papillomavirus. J Clin Microbiol (2003) 0.82
Cancer of the cervix - from bleak past to bright future; a review, with an emphasis on cancer of the cervix in malaysia. Malays J Med Sci (2003) 0.82
Asian society of gynecologic oncology workshop 2010. J Gynecol Oncol (2010) 0.81
Detection of human Papillomavirus 18 in cervical cancer samples using PCR-ELISA (DIAPOPS). Iran J Microbiol (2011) 0.78
Longitudinal analysis of carcinogenic human papillomavirus infection and associated cytologic abnormalities in the Guanacaste natural history study: looking ahead to cotesting. J Infect Dis (2011) 0.77
Human papillomavirus testing as a screening tool for cervical cancer. JAMA (2000) 0.77
Method for testing for human papillomavirus infection in patients with cervical intraepithelial disease. J Clin Microbiol (2004) 0.77
Oncogenic HPV Types Infection in Adolescents and University Women from North Portugal: From Self-Sampling to Cancer Prevention. J Oncol (2011) 0.77
Pap test results. Responding to Bethesda system reports. Can Fam Physician (2001) 0.75
Prospective comparison of hybrid capture 2 and SPF₁₀-LiPA for carcinogenic human papillomavirus detection and risk prediction of cervical cancer: a population-based cohort study in China. J Gynecol Oncol (2017) 0.75
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med (1997) 13.96
Improved amplification of genital human papillomaviruses. J Clin Microbiol (2000) 11.50
Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst (1993) 9.48
Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet Gynecol (1992) 7.14
Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis (1994) 7.00
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med (1999) 6.92
Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol (1986) 6.88
Residential exposure to magnetic fields and acute lymphoblastic leukemia in children. N Engl J Med (1997) 6.72
Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst (1993) 5.07
Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med (1998) 4.65
Does nondifferential misclassification of exposure always bias a true effect toward the null value? Am J Epidemiol (1990) 4.63
Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst (2000) 3.81
Design and methods of a population-based natural history study of cervical neoplasia in a rural province of Costa Rica: the Guanacaste Project. Rev Panam Salud Publica (1997) 3.67
Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin (2001) 3.65
Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet (1998) 3.61
Benzene and the dose-related incidence of hematologic neoplasms in China. Chinese Academy of Preventive Medicine--National Cancer Institute Benzene Study Group. J Natl Cancer Inst (1997) 3.61
Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol (1995) 3.59
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou results. JAMA (1999) 3.37
Human papillomavirus 16 E6 expression disrupts the p53-mediated cellular response to DNA damage. Proc Natl Acad Sci U S A (1993) 3.32
Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult Scler (2008) 3.28
Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine. J Natl Cancer Inst (2001) 3.28
Determination of left ventricular volumes by ultrasound. Circulation (1971) 3.09
Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions. J Natl Cancer Inst (1999) 2.98
Limitations of the case-only design for identifying gene-environment interactions. Am J Epidemiol (2001) 2.97
Cloning and characterization of the DNA of a new human papillomavirus from a woman with dysplasia of the uterine cervix. J Virol (1986) 2.93
Human papillomavirus--the most significant risk determinant of cervical intraepithelial neoplasia. Int J Cancer (1996) 2.91
The lifetime risks of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev (2001) 2.87
Recent advances in chemokines and chemokine receptors. Crit Rev Immunol (1999) 2.78
The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery. N Engl J Med (1984) 2.70
Established breast cancer risk factors by clinically important tumour characteristics. Br J Cancer (2006) 2.68
A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62
Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum Mol Genet (2000) 2.40
High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev (2001) 2.38
Controversy in primary care: Should asymptomatic haemochromatosis be treated? BMJ (2000) 2.36
A cell culture model of the blood-brain barrier. J Cell Biol (1991) 2.35
Prevalence of papillomavirus infection in women in Ibadan, Nigeria: a population-based study. Br J Cancer (2004) 2.33
Association between childhood acute lymphoblastic leukemia and use of electrical appliances during pregnancy and childhood. Epidemiology (1998) 2.33
The APCI1307K allele and cancer risk in a community-based study of Ashkenazi Jews. Nat Genet (1998) 2.32
A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis (2000) 2.24
Epidemiology of HPV infection among Mexican women with normal cervical cytology. Int J Cancer (2001) 2.22
Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J Clin Microbiol (1998) 2.21
Evaluation of seroreactivity to human papillomavirus type 16 virus-like particles in an incident case-control study of cervical neoplasia. J Infect Dis (1995) 2.21
Diet, tobacco use, and fatal prostate cancer: results from the Lutheran Brotherhood Cohort Study. Cancer Res (1990) 2.21
Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J Clin Microbiol (1991) 2.19
The incidence and significance of anti-natalizumab antibodies: results from AFFIRM and SENTINEL. Neurology (2007) 2.17
Non-differential misclassification and bias towards the null: a clarification. Occup Environ Med (1995) 2.15
Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J Virol (1995) 2.13
Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev (2001) 2.12
Determinants for genital human papillomavirus (HPV) infection in 1000 randomly chosen young Danish women with normal Pap smear: are there different risk profiles for oncogenic and nononcogenic HPV types? Cancer Epidemiol Biomarkers Prev (1997) 2.12
Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation. N Engl J Med (2001) 2.11
Comparison of cancers of the oral cavity and pharynx worldwide: etiological clues. Oral Oncol (2000) 2.06
Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey. Br J Pharmacol (1975) 2.05
The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet (1999) 2.03
Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus types. Am J Clin Pathol (1994) 2.00
Nucleotide sequence of human papillomavirus type 31: a cervical neoplasia-associated virus. Virology (1989) 1.95
Human papillomavirus infection and cervical cancer in Latin America. N Engl J Med (1989) 1.94
Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst (1998) 1.91
A qualitative study of patients' views on anxiety and depression. Br J Gen Pract (2001) 1.91
Human papillomavirus type 16 variants and risk of cervical cancer. J Natl Cancer Inst (2001) 1.86
High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. Eur J Clin Nutr (2010) 1.85
Are children living near high-voltage power lines at increased risk of acute lymphoblastic leukemia? Am J Epidemiol (2000) 1.82
Household solvent exposures and childhood acute lymphoblastic leukemia. Am J Public Health (2001) 1.80
Comparative sequence analysis reveals extensive microcolinearity in the lateral suppressor regions of the tomato, Arabidopsis, and Capsella genomes. Plant Cell (2001) 1.79
Non-viral risk factors for nasopharyngeal carcinoma in the Philippines: results from a case-control study. Int J Cancer (1993) 1.78
An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev (2001) 1.77
Relative and attributable risk for cervical cancer: a comparative study in the United States and Italy. Int J Epidemiol (1990) 1.77